Evidence map›Paper›PMID 33827582›Full record

ArticleMicrobial cell factories2021

Whole cell-based catalyst for enzymatic production of the osmolyte 2-O-α-glucosylglycerol.

Katharina N Schwaiger, Monika Cserjan-Puschmann, Gerald Striedner, Bernd Nidetzky

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Exogenous glucosylglycerol and proline extend the chronological lifespan of Rhodosporidium toruloides.International microbiology : the official journal of the Spanish Society for Microbiology · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Special Issue 'Microbial glycobiotechnology'.Microbial cell factories · 2022
    Article
  12. Article
  13. Engineering of a Thermostable Biocatalyst for the Synthesis of 2-O-Glucosylglycerol.Chembiochem : a European journal of chemical biology · 2021
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Katharina N SchwaigerAustrian Centre of Industrial Biotechnology (acib), Krenngasse 37, 8010, Graz, Austria.
Monika Cserjan-PuschmannAustrian Centre of Industrial Biotechnology (acib), Krenngasse 37, 8010, Graz, Austria.
Gerald StriednerAustrian Centre of Industrial Biotechnology (acib), Krenngasse 37, 8010, Graz, Austria.
Bernd NidetzkyAustrian Centre of Industrial Biotechnology (acib), Krenngasse 37, 8010, Graz, Austria. bernd.nidetzky@tugraz.at.ORCID http://orcid.org/0000-0002-5030-2643
Austrian Centre of Industrial Biotechnology (Austria) · ATGraz University of Technology · AT

Funding

Horizon 2020 Framework Programme No 761030 (CARBAFIN)
6 · The paper itself

Abstract

backgroundGlucosylglycerol (2-O-α-D-glucosyl-sn-glycerol; GG) is a natural osmolyte from bacteria and plants. It has promising applications as cosmetic and food-and-feed ingredient. Due to its natural scarcity, GG must be prepared through dedicated synthesis, and an industrial bioprocess for GG production has been implemented. This process uses sucrose phosphorylase (SucP)-catalyzed glycosylation of glycerol from sucrose, applying the isolated enzyme in immobilized form. A whole cell-based enzyme formulation might constitute an advanced catalyst for GG production. Here, recombinant production in Escherichia coli BL21(DE3) was compared systematically for the SucPs from Leuconostoc mesenteroides (LmSucP) and Bifidobacterium adolescentis (BaSucP) with the purpose of whole cell catalyst development.

resultsExpression from pQE30 and pET21 plasmids in E. coli BL21(DE3) gave recombinant protein at 40-50% share of total intracellular protein, with the monomeric LmSucP mostly soluble (≥ 80%) and the homodimeric BaSucP more prominently insoluble (~ 40%). The cell lysate specific activity of LmSucP was 2.8-fold (pET21; 70 ± 24 U/mg; N = 5) and 1.4-fold (pQE30; 54 ± 9 U/mg, N = 5) higher than that of BaSucP. Synthesis reactions revealed LmSucP was more regio-selective for glycerol glycosylation (~ 88%; position O2 compared to O1) than BaSucP (~ 66%), thus identifying LmSucP as the enzyme of choice for GG production. Fed-batch bioreactor cultivations at controlled low specific growth rate (µ = 0.05 h

conclusionsCompared to BaSucP, LmSucP is preferred for regio-selective GG production. Expression from pET21 and pQE30 plasmids enables high-yield bioreactor production of the enzyme as a whole cell catalyst. The freeze-thaw treated cells represent a highly active, solid formulation of the LmSucP for practical synthesis.

Indexed as

Escherichia coliGlucosidesRecombinant ProteinsGlucosidesglucosylglycerolRecombinant Proteins2-O-α-glucosylglycerolFed-batch fermentationHigh-yield protein expressionSucrose phosphorylaseWhole-cell biotransformation

Identifiers

PMID33827582
PMCPMC8025525
OpenAlexW3151345718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.